Association of NAT2 gene substitution mutation T341C with increased risk for head and neck cancer in Tunisia

Acta Oncologica

Volumn 46, Issue 6, 2007, Pages 834-837

  Gara, Sonia ^a,b   Abdennebi, Monia ^b   Chatti, Samia ^c   Touati, Slim ^a   Ladgham, Abderrahmen ^a   Guemira, Fethi ^a  

^a SALAH AZAIEZ INSTITUTE   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^c Nabeul Hospital   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENOTYPE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUNISIA;

ARYLAMINE N-ACETYLTRANSFERASE; CASE-CONTROL STUDIES; DISEASE SUSCEPTIBILITY; HEAD AND NECK NEOPLASMS; HUMANS; MUTATION; RISK FACTORS; TUNISIA;

EID: 34547144297     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860601096833     Document Type: Article

References (24)

1. Cloos J, Spitz MR, Schaniz SP, et al. Genetic susceptibility to head and neck squamous cell carcinoma. J Nail Cancer Inst 1996;88:530-5.
2. Risch A, Ramroth H, Raedts V, et al. Laryngeal cancer risk in Caucasians is associated with alcohol and tobacco consumption but not modified by genetic polymorphisms in class I alcohol dehydrogenases ADIIIB and ADIIIC, and glutathione S-transferases GSTM1 and GSTT1. Pharmacogenetics 2003;13:225-30.
3. Olshan AF, Weissler MC, Walson MA, Bell DA. GSTM1, GSTT1, GSTP1, CYPIA1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2000;9:185-91.
4. Kietthubthew S, Sriplung H, Au WW. Genetic and environnemental interactions on oral cancer in southern Thailand. Environ Mol Mutagen 2003;37:111-6.
5. Chen C, Ricks S, Doody DR, Fitzgibbons ED, Porter PL, Schwartz SM. N-Acetyltransferase 2 polymorphisms, cigarette smoking and alcohol consumption, and oral squamous cell cancer risk. Carcinogenesis 2001;22:1993-9.
6. Nizar- VS, Vaughan TL, Burt RD, Chen C, Berwik MG, Swanson M. Glutathione S transferase M1 and susceptibility to nasopharyngeal carcinoma. Cancer Epidemiol. Biomark. Prev 1999;8:547-51.
7. Murat Aoenal M, Laiafer Tamer PhD, Nurcan Aras Ates PhD, et al. Glutathione S-transferase M1, T1, and P1 gene polymorphism in laryngeal squamous cell carcinoma. Am J Otolaryngol 2004;25:318-22.
8. Shama C. Buch, Perin N. Notani, Rajani A. Bhisey. Polymorphism at GSTM1, GSTM3, and GSTT1 gene loci and susceptibility to oral cancer in an Indian population. Carcinogenesis. 2002;23:803-807.
9. Butcher NJ, Boukouvala S, Sim E, Minchin RF. Pharmacogenetics of the arylamine N-acetyltransferases. The pharma J 2002;2:30-42.
10. Hamdy SI, Hiratsuka M, Narahara K, et al. Genotype and allele frequencies of TPMT, NAT2, GST, SULTIAI and MDR-I in the Egyptian population. Br J Clin Pharmacol 2003;55:560-9.
11. Seidegard J, Pero R. the hereditary transmission of the high GST activity towords trans-stilbene oxide in the human mononuclear leukocytes. Human genetics 1985;69:66-8.
12. Pemble S, Schroeder K, Spencer S, et al. Human glutatione s-transferase theta (GSTT1): cDNA cloning and the charachterization of a genetic polymorphism. Biochem J 1994;300:271-6.
13. Longuemaux S, Deloménie C, Gallou C, Méjean A, Dupret JM. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes. Cancer Res 1999;59:2903-8.
14. Hahn M, Hagedorn G, Kuhlisch E, Schackert KH, Eckelt U. Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to oral cavity cancer. Oral Oncology 2002;38:486-90.
15. Mc Williams JE, Evans AJ, Beer TM, et al. Genetic polymorphisms in head and neck cancer risk. Head Neck 2000;22(6):609-17.
16. Park LY, Muscat JE, Kaur T, et al. Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and caucasiens. Pharmacogenetics 2000;10(2):123-31.
17. Hahn M, Hagedorn G, Kuhlisch E, Schackert KH, Eckelt U. Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to oral cavity cancer. Oral Oncology 2002;38:486-90.
18. Gronau S, Koning Creger D, Rettinger G, Riechelmann H. GSTM1 gene polymorphism in patients with head and neck tumors. Laryngorhinootologie 2000;79(6):341-4.
19. Miki S, Takayuki S, Toshiyuki I, Teruo A. Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer. Carcinogenesis 1999;20:1927-31.
20. Garte S. the role of ethnicity in cancer susceptibility gene polymorphisms the example of CYP1A1. Carcinogenesis 1998;19:1329-32.
21. Mareux PM, Vineis P, Rothman N. NAT2 slow acetylation and bladder cancer risk, meta-analysis of 22 case-control studies concludedin the general population. Pharmacogenetics 2000;10:115-22.
22. Ye Z, Song H, Guo Y. Gluthathione S-transferase M1, T1 status and the risk of head and neck cancer: a meta-analysis. BMJ 2004;41:360-5.
23. Gonzalez MV, Alvarez V, Pello MF, Menéndez MJ, Suarez C, Coto E. Genetic polymorphism of N-acetyltransferase-2, gluthatione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer. J Clin Pathol 1998;51:294-8.
24. Hein DW. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutation Res 2002;506-507:65-77.